{
  "page_1": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        170.43,
        78.71,
        424.45,
        99.7
      ],
      "y0": 78.71,
      "content": "조사우수사례 평가 보고서"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        406.7,
        111.36,
        530.44,
        123.35
      ],
      "y0": 111.36,
      "content": "(’25上 평가번호 : 22 )"
    },
    {
      "type": "yellow_table",
      "color": "yellow",
      "bbox": [
        65.0,
        133.0,
        531.0,
        189.5
      ],
      "y0": 133.0,
      "content": "개인·법인\n업종(코드)\n조사유형\n외형구간\n조사청\n법인\n제조업(242301)\n비정기\n7천억 원대\n지방청"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        69.32,
        214.12,
        231.59,
        233.06
      ],
      "y0": 214.12,
      "content": "Ⅰ\n조사성과(결과)"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.56,
        259.64,
        200.77,
        277.6
      ],
      "y0": 259.64,
      "content": "가. 조사대상개요"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        293.68,
        529.75,
        310.49
      ],
      "y0": 293.68,
      "content": "○(기업현황) 조사법인은의약품제조및판매업을영위하는사업자로,"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.59,
        316.09,
        528.79,
        332.92
      ],
      "y0": 316.09,
      "content": "각종영양수액및고지혈증치료제등다양한의약품을생산·공급중임"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        343.42,
        529.75,
        360.24
      ],
      "y0": 343.42,
      "content": "- (유통과정) 계열사▢▢▢▢㈜로부터수액류를매입하고있으며,"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.95,
        365.84,
        528.67,
        382.67
      ],
      "y0": 365.84,
      "content": "정제·캡슐제등의약품은당사○○공장에서생산하여병의원등에공급함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.56,
        403.0,
        161.79,
        420.96
      ],
      "y0": 403.0,
      "content": "나. 적출성과"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        436.32,
        195.73,
        453.14
      ],
      "y0": 436.32,
      "content": "○주요적출내역"
    },
    {
      "type": "yellow_table",
      "color": "yellow",
      "bbox": [
        64.5,
        465.5,
        526.5,
        634.0
      ],
      "y0": 465.5,
      "content": "연번\n조사항목\n코드\n적출요지(결정경정사유)\n①\n과다경비부인\n11201\n해시(HASH)값비교를통한새로운전산조사로\n중복등록된지출증빙관련손금부인\n②\n접대비한도초과\n11003\n이행의무\n없는\n반품거래를\n통한\n거래처\n매출채권임의포기\n③\n매출과세표준\n과소계상\n20102\n유통기한지난반품거래를‘재화의환입’으로\n편법처리하여VAT 과세표준과소계상\n④\n기타이전가격\n18003\n제품고가매입등을통한(결손)해외현지법인\n부당지원"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        649.45,
        529.75,
        666.27
      ],
      "y0": 649.45,
      "content": "⇒ 조사팀은서울청과학조사담당관실과협업, 120만건에이르는납"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.99,
        670.67,
        529.75,
        688.68
      ],
      "y0": 670.67,
      "content": "세자의방대한비용증빙중중복증빙을자동으로추출*해내는"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.99,
        694.16,
        529.75,
        710.98
      ],
      "y0": 694.16,
      "content": "‘새로운전산조사기법’ 등을적극활용하여○○○억원적출및"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.99,
        716.58,
        207.01,
        733.39
      ],
      "y0": 716.58,
      "content": "○○○억원과세"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        101.11,
        742.23,
        336.06,
        756.61
      ],
      "y0": 742.23,
      "content": "* 해시(HASH)값을대사하여중복자료추출"
    }
  ],
  "page_2": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        78.63,
        529.03,
        95.45
      ],
      "y0": 78.63,
      "content": "- 납세자는과세정당성을인정하여전체적출항목에대하여확인서"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.99,
        100.93,
        461.13,
        117.75
      ],
      "y0": 100.93,
      "content": "작성하고불복없이전액현금납부예정(조기결정신청)"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        69.32,
        172.4,
        201.49,
        191.35
      ],
      "y0": 172.4,
      "content": "Ⅱ\n조사노하우"
    },
    {
      "type": "yellow_table",
      "color": "yellow",
      "bbox": [
        68.0,
        217.5,
        529.0,
        273.5
      ],
      "y0": 217.5,
      "content": "적출□\n1\nv 과다경비 부인 (항목코드 : 11201)\n해시값 비교를 통해 중복등록된 지출증빙 관련 손금 부인"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        302.91,
        155.08,
        319.94
      ],
      "y0": 302.91,
      "content": "1. 조사착안"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.56,
        342.95,
        357.53,
        360.91
      ],
      "y0": 342.95,
      "content": "가. 제약업체제품설명회관련일반현황"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        377.11,
        529.03,
        393.92
      ],
      "y0": 377.11,
      "content": "○제약사가당사의약품에대한정보제공목적으로제품설명회를개최"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.11,
        399.4,
        529.75,
        416.22
      ],
      "y0": 399.4,
      "content": "하고참석한의사등에게약사법규정에따라1일10만이하의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.11,
        421.82,
        529.75,
        438.63
      ],
      "y0": 421.82,
      "content": "식사등을제공하는경우그지출액은판매부대비용에해당함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.11,
        444.59,
        192.16,
        458.97
      ],
      "y0": 444.59,
      "content": "(조심2021전6948)"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        67.5,
        478.0,
        528.0,
        638.5
      ],
      "y0": 478.0,
      "path": "crops/page_002\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.56,
        661.56,
        239.75,
        679.52
      ],
      "y0": 661.56,
      "content": "나. 착안사항도출과정"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        695.6,
        529.75,
        712.42
      ],
      "y0": 695.6,
      "content": "○제약사가접대성경비를제품설명회관련판매부대비용으로편법적"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.23,
        718.02,
        529.03,
        734.83
      ],
      "y0": 718.02,
      "content": "으로인정받기위하여동일한\n사진을서로\n다른\n제품설명회"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.23,
        740.31,
        527.59,
        757.13
      ],
      "y0": 740.31,
      "content": "개최증빙으로중복하여사용하고있는사례등중요혐의사항발견"
    }
  ],
  "page_3": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        78.63,
        529.75,
        95.45
      ],
      "y0": 78.63,
      "content": "- 조사법인은제품설명회관련비용을판매부대비용으로처리하고"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.99,
        102.37,
        529.75,
        119.18
      ],
      "y0": 102.37,
      "content": "있으며, 영업활동을기록하는자체프로그램(○○-web)을개발하여"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.99,
        126.1,
        491.13,
        142.92
      ],
      "y0": 126.1,
      "content": "모든지출건에대하여증빙자료(사진)를첨부(저장)하고있음"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        159.91,
        529.03,
        176.72
      ],
      "y0": 159.91,
      "content": "- 하지만, 프로그램에접속하여증빙자료샘플링한결과서로다른"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.31,
        183.64,
        529.75,
        200.45
      ],
      "y0": 183.64,
      "content": "지출건에대해동일증빙이사용된부적정사례를확인하고"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.31,
        207.49,
        192.38,
        224.31
      ],
      "y0": 207.49,
      "content": "조사역량집중"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        260.36,
        155.08,
        277.38
      ],
      "y0": 260.36,
      "content": "2. 조사기법"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        300.39,
        341.57,
        318.36
      ],
      "y0": 300.39,
      "content": "가. 업종특성및전산자료현황분석"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        334.43,
        330.3,
        352.4
      ],
      "y0": 334.43,
      "content": "1) 제약업종및조사법인특성파악"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        367.4,
        529.75,
        385.29
      ],
      "y0": 367.4,
      "content": "○국내제약산업은내수용완제품중심의의약품위주*로운영되어"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.31,
        390.89,
        526.52,
        407.71
      ],
      "y0": 390.89,
      "content": "구조적으로영업비지출(리베이트)에따라매출상관성이크게좌우됨"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        95.11,
        418.58,
        529.75,
        432.97
      ],
      "y0": 418.58,
      "content": "* 의약품의라이프사이클이짧고, 신약개발투자비보다는상대적으로판매"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.62,
        435.96,
        529.75,
        467.73
      ],
      "y0": 435.96,
      "content": "비용의비중이높으며, 특허권으로보호되는의약품에비해부가가치및영업\n기반이취약"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        480.32,
        529.75,
        497.13
      ],
      "y0": 480.32,
      "content": "○조사법인은수십년간운영된전통적인중견제약사로수익보다는"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.35,
        502.73,
        447.72,
        519.55
      ],
      "y0": 502.73,
      "content": "영업비등비용측면에서문제점이있을것으로판단"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        533.06,
        529.75,
        549.87
      ],
      "y0": 533.06,
      "content": "- 다만, 제약사특성상우리청외에도관계기관(공정위, 식약처, 검․경)에서"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.71,
        555.47,
        529.75,
        572.29
      ],
      "y0": 555.47,
      "content": "집중\n관리(압수수색\n등)하므로\n기존의\n조사기법으로는\n조사목표"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.71,
        577.89,
        177.5,
        594.7
      ],
      "y0": 577.89,
      "content": "달성에한계"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        615.05,
        338.58,
        633.01
      ],
      "y0": 615.05,
      "content": "2) 신속하고체계적인전산자료확보"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        649.21,
        529.75,
        666.03
      ],
      "y0": 649.21,
      "content": "○최근기업들의보안강화추세및대용량파일규모등으로전산"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.83,
        671.51,
        529.75,
        688.32
      ],
      "y0": 671.51,
      "content": "자료를조기에확보하기가어려운점을고려, 착수당일에전산"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.83,
        693.92,
        529.03,
        710.74
      ],
      "y0": 693.92,
      "content": "시스템별운영현황을우선파악하여위변조방지조치하고, 체계"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.83,
        716.34,
        236.15,
        733.15
      ],
      "y0": 716.34,
      "content": "적인자료확보실시"
    }
  ],
  "page_4": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        112.14,
        81.44,
        482.94,
        95.47
      ],
      "y0": 81.44,
      "content": "<  조사법인의 전산시스템 별 자료확보 현황 분석(착수 당일) >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        67.5,
        103.5,
        530.5,
        379.5
      ],
      "y0": 103.5,
      "path": "crops/page_004\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        149.56,
        406.04,
        445.52,
        420.07
      ],
      "y0": 406.04,
      "content": "<  전산 운용 관련 주요 인터뷰 내용(착수 당일) >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        429.0,
        529.0,
        561.0
      ],
      "y0": 429.0,
      "path": "crops/page_004\\blue_001.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        574.29,
        533.84,
        591.12
      ],
      "y0": 574.29,
      "content": "※ 착수 당일에 파일 목록, 조회권한 등을 우선 확보 및 위변조 방지 조치하고,"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.03,
        599.34,
        459.83,
        611.33
      ],
      "y0": 599.34,
      "content": "파일 본문과 기안문서 등 기타 자료들은 조기에 순차적으로 확보"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        623.56,
        533.96,
        635.55
      ],
      "y0": 623.56,
      "content": "- 주요 시스템(문서중앙화, 전자결재, 영업관리 웹)에 대한 접근권한 및 외부"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        101.94,
        642.74,
        404.9,
        654.73
      ],
      "y0": 642.74,
      "content": "접속용 노트북 확보 완료하고, 자료 제출상황 철저 관리"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        674.02,
        389.67,
        691.99
      ],
      "y0": 674.02,
      "content": "나. 기본적인전산조사로주요혐의사항도출"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        708.07,
        529.03,
        724.88
      ],
      "y0": 708.07,
      "content": "○체계적으로확보한전산자료를심층분석하여제품설명회관련편법"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.99,
        730.48,
        352.97,
        747.3
      ],
      "y0": 730.48,
      "content": "적인경비처리혐의를유형별로확인"
    }
  ],
  "page_5": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        78.51,
        367.72,
        96.48
      ],
      "y0": 78.51,
      "content": "1) (혐의유형➊) 유사한사진증빙등록"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        112.56,
        529.75,
        129.37
      ],
      "y0": 112.56,
      "content": "○조사법인은제품설명회의개최증빙으로영업사원들로부터현장"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.31,
        134.97,
        529.75,
        151.79
      ],
      "y0": 134.97,
      "content": "사진및방명록등을제출받고있으나, 유사한사진및방명록등을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.31,
        157.27,
        443.16,
        174.08
      ],
      "y0": 157.27,
      "content": "등록하여제품설명회없이식사등만을제공한혐의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        189.63,
        529.75,
        206.45
      ],
      "y0": 189.63,
      "content": "- (같은날촬영사진활용) ’21. 11월과12월에개최한제품설명회의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.47,
        212.05,
        529.75,
        228.86
      ],
      "y0": 212.05,
      "content": "증빙사진을보면, 등장인물및배경이아래와같이거의유사한"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.47,
        234.46,
        529.03,
        251.28
      ],
      "y0": 234.46,
      "content": "것으로보아같은날여러장촬영한사진을다른일자의증빙으로"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.47,
        256.76,
        170.91,
        273.58
      ],
      "y0": 256.76,
      "content": "사용한혐의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        176.18,
        289.8,
        424.4,
        302.74
      ],
      "y0": 289.8,
      "content": "< ○○병원 제품설명회 사진 증빙(예시) >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        68.5,
        311.5,
        529.0,
        503.5
      ],
      "y0": 311.5,
      "path": "crops/page_005\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        515.44,
        529.75,
        532.25
      ],
      "y0": 515.44,
      "content": "- (방명록필체유사) 제품설명회참석방명록을확인한바, 참석자"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        93.07,
        540.61,
        488.38,
        557.42
      ],
      "y0": 540.61,
      "content": "이름및서명의필체가한명이작성한것처럼유사한혐의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        168.51,
        576.4,
        429.93,
        589.35
      ],
      "y0": 576.4,
      "content": "< ○○병원 제품설명회 방명록 자료(예시) >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        592.5,
        529.5,
        767.5
      ],
      "y0": 592.5,
      "path": "crops/page_005\\blue_001.png"
    }
  ],
  "page_6": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        83.43,
        518.36,
        101.39
      ],
      "y0": 83.43,
      "content": "2) (혐의유형➋) 동일한제품에대해 수차례 제품설명회개최"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        117.59,
        529.75,
        134.41
      ],
      "y0": 117.59,
      "content": "○‘경제적이익지출보고서(’21년~’23년)’상소규모병의원에는A제품,"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        101.11,
        139.89,
        529.75,
        156.7
      ],
      "y0": 139.89,
      "content": "대형병원에는B제품이라는동일한정보를3년간제공한것처럼"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        101.11,
        162.3,
        376.84,
        179.12
      ],
      "y0": 162.3,
      "content": "처리하고, 매년20~40차례식사등을제공"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        94.63,
        197.54,
        500.45,
        212.53
      ],
      "y0": 197.54,
      "content": "<  특정 의약품에 대한 제품설명회 개최 후 식사제공 횟수(예시) >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        231.5,
        531.5,
        362.5
      ],
      "y0": 231.5,
      "path": "crops/page_006\\blue_001.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        155.2,
        377.52,
        440.0,
        391.54
      ],
      "y0": 377.52,
      "content": "<  동일 의약품의 제품설명회 증빙 사진(예시) >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        405.5,
        538.0,
        565.0
      ],
      "y0": 405.5,
      "path": "crops/page_006\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        592.99,
        481.66,
        610.96
      ],
      "y0": 592.99,
      "content": "3) (혐의유형➌) 참석인원수를부풀려 제품설명회개최"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        627.03,
        529.75,
        643.86
      ],
      "y0": 627.03,
      "content": "○‘경제적이익지출보고서’에따르면강남○○○○병원내과의국에"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.39,
        649.45,
        427.33,
        666.27
      ],
      "y0": 649.45,
      "content": "매주월요일, 동일한의사들(27명)에게식사를제공"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        679.78,
        529.75,
        696.59
      ],
      "y0": 679.78,
      "content": "- 조사법인은의사등이휴가등사유로매번제품설명회참석이불"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.87,
        702.19,
        529.75,
        719.01
      ],
      "y0": 702.19,
      "content": "가할수있음에도동일한인원에게식사등을제공한것처럼신고"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.87,
        724.49,
        381.39,
        741.3
      ],
      "y0": 724.49,
      "content": "하여, 제품설명회참석인원수를부풀린혐의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        91.51,
        751.82,
        497.45,
        767.35
      ],
      "y0": 751.82,
      "content": "* 증빙사진상으로도27명의인원이참석한사실을확인할수없음"
    }
  ],
  "page_7": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        167.67,
        79.71,
        427.41,
        95.47
      ],
      "y0": 79.71,
      "content": "<  제품설명회후식사제공인원수(예시) >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        67.0,
        107.5,
        529.0,
        173.0
      ],
      "y0": 107.5,
      "path": "crops/page_007\\blue_001.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        202.34,
        525.08,
        220.3
      ],
      "y0": 202.34,
      "content": "4) (혐의유형➍) 코로나19 기간중제품설명회없이식사제공"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        236.38,
        529.75,
        253.2
      ],
      "y0": 236.38,
      "content": "○조사대상기간은코로나19 팬데믹기간으로당시대학병원등은"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.15,
        260.12,
        529.75,
        276.93
      ],
      "y0": 260.12,
      "content": "전염병확산을방지하기위하여일반인들의병원출입을엄격히"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.15,
        283.97,
        171.63,
        300.79
      ],
      "y0": 283.97,
      "content": "제한하였음"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        317.65,
        529.75,
        334.47
      ],
      "y0": 317.65,
      "content": "- 영업사원이제출한특정병원식사제공증빙사진에따르면도시"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.07,
        341.51,
        529.75,
        358.32
      ],
      "y0": 341.51,
      "content": "락을병원외부에서수령하여반입한것으로확인되며, 실제영업"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.07,
        365.24,
        529.03,
        382.06
      ],
      "y0": 365.24,
      "content": "사원은병원출입이제한됨에따라제품설명회없이식사(도시락)만"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.07,
        388.97,
        177.5,
        405.79
      ],
      "y0": 388.97,
      "content": "제공한혐의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        71.96,
        429.08,
        530.19,
        442.03
      ],
      "y0": 429.08,
      "content": "< 코로나 기간 중 출입제한 안내문 >\n< 코로나 기간 중 식사 제공 증빙 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        448.0,
        538.0,
        648.5
      ],
      "y0": 448.0,
      "path": "crops/page_007\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        669.95,
        353.09,
        687.91
      ],
      "y0": 669.95,
      "content": "다. 새로운전산조사기법으로적출확정"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.08,
        703.99,
        529.03,
        720.81
      ],
      "y0": 703.99,
      "content": "○서울청과학조사담당관실과긴밀히협업하여중복된전산증빙을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.83,
        726.41,
        529.75,
        743.22
      ],
      "y0": 726.41,
      "content": "일괄추출하는새로운전산조사기법을추가로활용하여최종"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.83,
        748.7,
        187.94,
        765.52
      ],
      "y0": 748.7,
      "content": "적출금액산출"
    }
  ],
  "page_8": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        73.6,
        529.75,
        90.42
      ],
      "y0": 73.6,
      "content": "- 조사팀은기본적인전산조사를통해제품설명회개최증빙이중복된"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        91.15,
        96.02,
        529.75,
        112.83
      ],
      "y0": 96.02,
      "content": "일부샘플링자료를유형별로확인하였으나, 이는수많은방대한"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        91.15,
        118.31,
        529.75,
        135.13
      ],
      "y0": 118.31,
      "content": "전체증빙중극히일부에불과하여실제적출금액으로연결하기는"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        91.15,
        140.73,
        168.15,
        157.54
      ],
      "y0": 140.73,
      "content": "어려운상황"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        168.06,
        529.03,
        184.87
      ],
      "y0": 168.06,
      "content": "- 이에회사자체개발프로그램(○○-web)에연동된전자증빙의해시"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.95,
        190.47,
        529.75,
        207.29
      ],
      "y0": 190.47,
      "content": "(HASH)* 값을대사하여중복자료추출하는창의적인전산조사"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.95,
        212.89,
        529.03,
        229.7
      ],
      "y0": 212.89,
      "content": "기법을추가로활용하여한정된조사기간내에효율적인전산자료"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.95,
        235.18,
        157.36,
        252.0
      ],
      "y0": 235.18,
      "content": "검증실시"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        264.79,
        529.75,
        280.33
      ],
      "y0": 264.79,
      "content": "＊해시(HASH)란디지털파일이가진숫자와알파벳을특정함수에넣어서"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.15,
        283.01,
        529.75,
        316.65
      ],
      "y0": 283.01,
      "content": "얻어지는파일의고유값으로디지털포렌식에서파일의동일성을입증하\n는증거로쓰임"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        324.13,
        529.75,
        340.94
      ],
      "y0": 324.13,
      "content": "- 서울청과학조사담당관실에협조요청하여전체전자증빙에대한"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.47,
        346.54,
        501.81,
        363.36
      ],
      "y0": 346.54,
      "content": "고유한해시값을생성하고중복자료일괄대사및검증실시"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        377.0,
        529.5,
        482.5
      ],
      "y0": 377.0,
      "path": "crops/page_008\\blue_001.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        80.12,
        499.01,
        529.75,
        516.98
      ],
      "y0": 499.01,
      "content": "1) (전자증빙확보) 회사자체개발프로그램(○○-web)으로부터추출한"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.27,
        523.11,
        529.75,
        539.92
      ],
      "y0": 523.11,
      "content": "120만\n건에\n이르는\n대량\n전자증빙자료(이미지파일.jpg)에\n대해"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.27,
        545.52,
        526.75,
        562.34
      ],
      "y0": 545.52,
      "content": "국세청통합조사프로그램(NFT 1.2.5)을사용하여해시(hash)값생성"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        179.78,
        575.68,
        415.29,
        588.63
      ],
      "y0": 575.68,
      "content": "< 통합조사 프로그램 활용 방법(예시) >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        67.5,
        594.0,
        531.0,
        767.0
      ],
      "y0": 594.0,
      "path": "crops/page_008\\blue_000.png"
    }
  ],
  "page_9": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        80.12,
        78.51,
        529.75,
        96.48
      ],
      "y0": 78.51,
      "content": "2)\n(중복증빙\n추출)\n통합조사\n프로그램에서\n생성된\n해시값\n목록"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        104.58,
        102.61,
        529.75,
        119.42
      ],
      "y0": 102.61,
      "content": "(Excel)에서동일한해시값을가지는파일을함수로일괄추출하여"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        104.58,
        124.9,
        199.21,
        141.72
      ],
      "y0": 124.9,
      "content": "중복증빙검토"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        67.5,
        157.0,
        528.5,
        406.5
      ],
      "y0": 157.0,
      "path": "crops/page_009\\blue_001.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.64,
        421.7,
        529.75,
        439.66
      ],
      "y0": 421.7,
      "content": "3) (부당경비확정) 중복증빙지출건에대하여영업사원활동기록및"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.67,
        445.79,
        375.64,
        462.61
      ],
      "y0": 445.79,
      "content": "회계전표와비교하여부당경비일괄적출"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        68.5,
        495.0,
        528.5,
        765.0
      ],
      "y0": 495.0,
      "path": "crops/page_009\\blue_000.png"
    }
  ],
  "page_10": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.56,
        68.45,
        167.55,
        86.41
      ],
      "y0": 68.45,
      "content": "라. 적출내역"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        102.61,
        529.75,
        119.42
      ],
      "y0": 102.61,
      "content": "○제품설명회관련경비로손금처리한판매부대비용중중복증빙"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.15,
        124.9,
        529.03,
        141.72
      ],
      "y0": 124.9,
      "content": "첨부등으로제품설명회개최여부가확인되지않는경비○○억원"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.15,
        147.32,
        529.62,
        164.13
      ],
      "y0": 147.32,
      "content": "부인하고그귀속자불분명하여대표자상여처분함(관련VAT도추징)"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        174.65,
        529.75,
        191.46
      ],
      "y0": 174.65,
      "content": "- 조사법인의전산에등록된전자증빙약120만건의해시값을비교한"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        91.15,
        197.06,
        529.75,
        213.89
      ],
      "y0": 197.06,
      "content": "결과중복값을가지는파일약○만건을확인하고, 관련자료와회사"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        91.15,
        219.48,
        360.89,
        236.3
      ],
      "y0": 219.48,
      "content": "프로그램상활동기록및회계전표와대사"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        246.81,
        529.75,
        263.64
      ],
      "y0": 246.81,
      "content": "⇒중복증빙지출건에대해회사에일괄소명요구하고, 소명되지않은"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.39,
        269.23,
        529.75,
        286.06
      ],
      "y0": 269.23,
      "content": "○만여건에대한지출을사용처와귀속이불분명한경비로보아"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.39,
        291.52,
        191.42,
        308.35
      ],
      "y0": 291.52,
      "content": "○○억원적출"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.32,
        333.84,
        272.61,
        351.8
      ],
      "y0": 333.84,
      "content": "마. 납세자주장및과세논리"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        367.88,
        529.03,
        384.69
      ],
      "y0": 367.88,
      "content": "○(납세자주장) 개별지출건에대한제품설명회의업무연관성은"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.35,
        390.29,
        459.71,
        407.11
      ],
      "y0": 390.29,
      "content": "저장된사진(이미지파일)을통하여입증가능하다고주장"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        85.63,
        422.66,
        529.75,
        439.47
      ],
      "y0": 422.66,
      "content": "- 회사는제품설명회관련경비의경우접대성경비와구분이모호하여"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.39,
        444.95,
        529.75,
        461.77
      ],
      "y0": 444.95,
      "content": "소액(50만원이하)도업무관련성여부를입증하기위해자체개발한"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.39,
        467.37,
        529.03,
        484.18
      ],
      "y0": 467.37,
      "content": "프로그램에\n관련증빙사진을모두이미지파일로첨부하는등철저히"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.39,
        489.78,
        202.81,
        506.6
      ],
      "y0": 489.78,
      "content": "관리한다고답변"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        522.15,
        529.75,
        538.96
      ],
      "y0": 522.15,
      "content": "○(조사팀과세) 조사팀은일부전자증빙자료가중복으로사용된"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.27,
        544.45,
        529.03,
        561.26
      ],
      "y0": 544.45,
      "content": "혐의에착안하여120만건에이르는대량증빙의해시값을전부"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.27,
        566.86,
        529.27,
        583.68
      ],
      "y0": 566.86,
      "content": "대사하고전자증빙중상당수를변칙적으로중복사용한사실을규명"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        599.23,
        529.03,
        616.04
      ],
      "y0": 599.23,
      "content": "- 제품설명회\n개최여부가\n확인되지\n않는\n사용처\n불분명\n경비"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        101.58,
        621.64,
        200.89,
        638.47
      ],
      "y0": 621.64,
      "content": "○○억원적출"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.32,
        658.8,
        234.83,
        676.77
      ],
      "y0": 658.8,
      "content": "바. 핵심증거자료확보"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        692.96,
        529.75,
        709.78
      ],
      "y0": 692.96,
      "content": "○조사팀은영업관련경비지출액이소액(건별50만원이하)이고회사가"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.99,
        715.26,
        529.75,
        732.07
      ],
      "y0": 715.26,
      "content": "증빙자료를모두전산에수록하여해당경비는모두적법한업무"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.99,
        737.67,
        416.3,
        754.49
      ],
      "y0": 737.67,
      "content": "관련경비일것이라고일반화하여판단하지않고,"
    }
  ],
  "page_11": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        73.6,
        529.75,
        90.42
      ],
      "y0": 73.6,
      "content": "- 국세청통합조사프로그램(NFT 1.2.5)을사용하여120만건에이르는"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.59,
        96.02,
        509.72,
        112.83
      ],
      "y0": 96.02,
      "content": "대량의증빙자료를해쉬값으로대사하여중복자료를일괄추출"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        123.35,
        529.03,
        140.16
      ],
      "y0": 123.35,
      "content": "- 추출한중복증빙자료를근거로납세자부터해당지출건이업무"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.91,
        145.76,
        433.68,
        162.58
      ],
      "y0": 145.76,
      "content": "관련성을입증할수없는비용임을최종확인받음"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        68.0,
        205.0,
        529.0,
        261.0
      ],
      "y0": 205.0,
      "path": "crops/page_011\\blue_001.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        292.45,
        149.68,
        308.4
      ],
      "y0": 292.45,
      "content": "1. 조사착안"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.56,
        330.84,
        239.75,
        348.8
      ],
      "y0": 330.84,
      "content": "가. 착안사항도출과정"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        365.0,
        529.75,
        381.82
      ],
      "y0": 365.0,
      "content": "○조사법인은매출처에대한대금회수기한이6개월이초과되는"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.31,
        387.3,
        529.75,
        404.11
      ],
      "y0": 387.3,
      "content": "시점부터거래처에대한강제집행등추심절차를진행하는것으로"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.31,
        409.71,
        351.07,
        426.53
      ],
      "y0": 409.71,
      "content": "확인(채권관리팀소속직원과의인터뷰실시)"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        441.0,
        529.75,
        458.91
      ],
      "y0": 441.0,
      "content": "- 하지만대구·경북지역소재특정\n도매상*(이하‘특정도매상’)에"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.39,
        464.49,
        529.75,
        481.31
      ],
      "y0": 464.49,
      "content": "대하여는3년이상경과한고액의장기매출채권을보유하고"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.39,
        486.79,
        493.53,
        503.6
      ],
      "y0": 486.79,
      "content": "있음에도불구하고추심절차를진행하지않은특이사항발견"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.59,
        515.32,
        383.07,
        530.85
      ],
      "y0": 515.32,
      "content": "* 조사법인과현재도계속거래중인사업자들임"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        177.98,
        550.03,
        417.21,
        562.98
      ],
      "y0": 550.03,
      "content": "< 연도별 특정 도매상 매출채권 내역 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        577.0,
        529.5,
        752.0
      ],
      "y0": 577.0,
      "path": "crops/page_011\\blue_000.png"
    }
  ],
  "page_12": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        78.63,
        529.75,
        95.45
      ],
      "y0": 78.63,
      "content": "- 또한조사법인은이들장기미회수매출채권을보유한특정도매상을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        90.79,
        100.93,
        510.8,
        117.75
      ],
      "y0": 100.93,
      "content": "대상으로매년고액의(-)세금계산서를발행한사실을추가확인"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        138.21,
        169.95,
        156.17
      ],
      "y0": 138.21,
      "content": "나. 착안내용"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        172.25,
        529.75,
        189.07
      ],
      "y0": 172.25,
      "content": "○조사법인이장기매출채권을보유한특정도매상에대한채권을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.51,
        194.67,
        529.75,
        211.48
      ],
      "y0": 194.67,
      "content": "정리하기위하여강제추심등통한현금회수가아니라, 고액의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.51,
        217.08,
        529.75,
        233.9
      ],
      "y0": 217.08,
      "content": "(-)세금계산서를\n발행하여매출채권및VAT 매출과세표준을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.51,
        239.38,
        278.13,
        256.19
      ],
      "y0": 239.38,
      "content": "차감하고있는점에착안함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        289.33,
        149.68,
        305.28
      ],
      "y0": 289.33,
      "content": "2. 조사기법"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        327.84,
        200.77,
        345.81
      ],
      "y0": 327.84,
      "content": "가. 주요사실관계"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        361.88,
        529.75,
        378.7
      ],
      "y0": 361.88,
      "content": "○(특판매출) 조사법인은’15년~’19년의약품시장확장을위하여일부"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.23,
        384.3,
        529.03,
        401.13
      ],
      "y0": 384.3,
      "content": "경구제의약품을대구·경북지역특정도매상을대상으로외상으로"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.23,
        406.6,
        195.84,
        423.41
      ],
      "y0": 406.6,
      "content": "대량판매(특판)"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        438.96,
        529.74,
        455.78
      ],
      "y0": 438.96,
      "content": "- 이후판매가부진하자당초판매가격으로다시반품(이하‘특수_반품’)"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.11,
        461.38,
        394.35,
        478.21
      ],
      "y0": 461.38,
      "content": "받으면서○○○억원의(-)세금계산서를발급"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        207.85,
        504.96,
        401.62,
        517.91
      ],
      "y0": 504.96,
      "content": "< 특정거래처 반품 거래 내역 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        535.0,
        543.5,
        681.0
      ],
      "y0": 535.0,
      "path": "crops/page_012\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        697.52,
        529.03,
        714.33
      ],
      "y0": 697.52,
      "content": "- 회사는‘특수_반품’ 거래에대해(-)세금계산서를발행하여매출과표"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.07,
        719.93,
        475.06,
        736.75
      ],
      "y0": 719.93,
      "content": "에서차감하면서, 동시에기존매출채권에서상계처리함"
    }
  ],
  "page_13": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.56,
        83.43,
        169.23,
        101.39
      ],
      "y0": 83.43,
      "content": "나. 적출내역"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        117.59,
        529.75,
        134.41
      ],
      "y0": 117.59,
      "content": "○(접대성경비) 조사법인이반품의무가없는의약품을특정도매상"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        96.91,
        141.33,
        529.75,
        158.14
      ],
      "y0": 141.33,
      "content": "으로부터당초판매가격으로반품받아매출액및매출채권에서차감한"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        96.91,
        165.06,
        460.31,
        181.88
      ],
      "y0": 165.06,
      "content": "것은거래처에대한접대목적의접대성경비에해당함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        198.86,
        529.75,
        215.68
      ],
      "y0": 198.86,
      "content": "- 조사법인이도매상과체결한[표준대리점거래계약서]에따르면"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        101.7,
        222.6,
        529.75,
        239.41
      ],
      "y0": 222.6,
      "content": "‘유통기한까지12개월이상남아있고, 재판매가가능한의약품의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        101.7,
        246.45,
        386.07,
        263.27
      ],
      "y0": 246.45,
      "content": "경우’에한해반품의무가있는것으로확인"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        67.5,
        274.5,
        531.5,
        398.5
      ],
      "y0": 274.5,
      "path": "crops/page_013\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.32,
        419.06,
        272.61,
        437.03
      ],
      "y0": 419.06,
      "content": "다. 납세자주장및과세논리"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        453.22,
        177.62,
        470.04
      ],
      "y0": 453.22,
      "content": "1) 납세자주장"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        485.59,
        529.75,
        502.4
      ],
      "y0": 485.59,
      "content": "○조사법인은반품거래를통한매출채권감액이사회통념또는"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.58,
        507.88,
        529.03,
        524.7
      ],
      "y0": 507.88,
      "content": "상관행에비추어제품의판매에직접관련하여정상적으로소요되는"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.58,
        530.3,
        527.95,
        547.12
      ],
      "y0": 530.3,
      "content": "비용이며, 이는손비로인정되는판매부대비용에해당한다고주장"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        93.07,
        562.67,
        529.75,
        579.48
      ],
      "y0": 562.67,
      "content": "- 국내제약업계는과거부터치열한경쟁관계속에서일반적인"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.82,
        585.08,
        529.75,
        601.9
      ],
      "y0": 585.08,
      "content": "‘표준대리점거래계약서’에도불구하고거래처가요구하는반품을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.82,
        607.38,
        529.75,
        624.19
      ],
      "y0": 607.38,
      "content": "임의로받아주는관행이업계전반에걸쳐광범위하게지속되어"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.82,
        629.79,
        184.82,
        646.61
      ],
      "y0": 629.79,
      "content": "왔다고답변"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        662.16,
        265.18,
        678.97
      ],
      "y0": 662.16,
      "content": "2) 반품거래내역중점조사"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        694.52,
        529.75,
        711.34
      ],
      "y0": 694.52,
      "content": "○조사법인의‘특수_반품’ 거래는통상적인일반반품거래와달리"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.34,
        716.94,
        529.03,
        733.75
      ],
      "y0": 716.94,
      "content": "대부분유통기한이경과하여재판매가불가능하고, 오히려폐기처분"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.34,
        739.23,
        526.87,
        756.05
      ],
      "y0": 739.23,
      "content": "대상에해당하여조사법인이폐기비용까지부담하는것으로확인"
    }
  ],
  "page_14": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        78.63,
        529.03,
        95.45
      ],
      "y0": 78.63,
      "content": "가) (유통기한경과) 특정도매상으로부터반품받은제품들의거래명"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        105.9,
        100.93,
        529.03,
        117.75
      ],
      "y0": 100.93,
      "content": "세서확인결과, 조사법인은‘특수_반품’ 거래를통하여유통기한이"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        105.9,
        123.35,
        504.57,
        140.16
      ],
      "y0": 123.35,
      "content": "2~4년이나지나재판매가불가능한의약품을인수한사실확인"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        206.17,
        160.53,
        393.32,
        173.48
      ],
      "y0": 160.53,
      "content": "< 특판_반품 거래명세서 예시 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        183.0,
        531.5,
        466.5
      ],
      "y0": 183.0,
      "path": "crops/page_014\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        484.51,
        529.75,
        501.33
      ],
      "y0": 484.51,
      "content": "나) (폐기처분) 조사법인은유통기한내의약품을반품받는일반적인"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.38,
        508.36,
        529.75,
        525.18
      ],
      "y0": 508.36,
      "content": "경우반품제품을A급으로분류하여재판매하고있으나, ‘특수_반"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.38,
        532.1,
        529.75,
        548.91
      ],
      "y0": 532.1,
      "content": "품’의경우유통기한이경과하여반품즉시전량폐기처분하고"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.38,
        555.83,
        232.31,
        572.65
      ],
      "y0": 555.83,
      "content": "있는것으로확인됨"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        589.64,
        529.75,
        606.45
      ],
      "y0": 589.64,
      "content": "○지방○○시에소재한조사법인의○○물류창고를현장방문하여"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        108.3,
        612.05,
        526.87,
        628.87
      ],
      "y0": 612.05,
      "content": "‘특수_반품’\n처리현황확인한바, 전량폐기처분해온사실확인"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        654.36,
        155.44,
        671.18
      ],
      "y0": 654.36,
      "content": "3) 과세논리"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        691.76,
        316.99,
        708.58
      ],
      "y0": 691.76,
      "content": "가) 법인세법상접대비시부인대상"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        724.13,
        529.03,
        740.94
      ],
      "y0": 724.13,
      "content": "○(접대성경비) 조사법인은반품이행의무가없는대량의폐기대상"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.62,
        746.42,
        529.03,
        763.24
      ],
      "y0": 746.42,
      "content": "의약품을반품받은것은거래처와의관계개선등의목적으로매출"
    }
  ],
  "page_15": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.62,
        68.57,
        529.75,
        85.38
      ],
      "y0": 68.57,
      "content": "채권을임의로포기하였다고봄이타당하며, 통상적인판매부대"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.62,
        90.98,
        239.63,
        107.8
      ],
      "y0": 90.98,
      "content": "비용으로볼수없음"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        118.31,
        529.75,
        135.13
      ],
      "y0": 118.31,
      "content": "⇒ 반품거래를통하여거래매출채권을임의포기한금액을법인세"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.1,
        140.73,
        528.79,
        157.56
      ],
      "y0": 140.73,
      "content": "법§25에따른접대성경비로보아접대비시부인대상○○○억원적출"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        178.13,
        304.04,
        194.94
      ],
      "y0": 178.13,
      "content": "나) VAT 매출과세표준신고누락"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        210.49,
        529.75,
        227.32
      ],
      "y0": 210.49,
      "content": "○(제품환입여부) 부가법§29 ①에따르면매출과세표준은해당과세"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        105.06,
        232.79,
        529.75,
        249.6
      ],
      "y0": 232.79,
      "content": "기간에공급한재화또는용역의공급가액을합한금액으로한다고"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        105.06,
        255.2,
        529.03,
        272.02
      ],
      "y0": 255.2,
      "content": "규정하고⑤항에서공급가액에포함하지아니하는항목을예외적"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        105.06,
        277.62,
        170.19,
        294.43
      ],
      "y0": 277.62,
      "content": "으로열거"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        93.07,
        309.98,
        529.75,
        326.81
      ],
      "y0": 309.98,
      "content": "- 2호에서환입된재화의가액을규정하고있으며, 부가령§70조는"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.26,
        332.28,
        529.75,
        349.09
      ],
      "y0": 332.28,
      "content": "재화의환입등일정한경우수정세금계산서를발급할수있다고"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.26,
        354.69,
        148.24,
        371.51
      ],
      "y0": 354.69,
      "content": "규정함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        93.07,
        387.06,
        529.75,
        403.87
      ],
      "y0": 387.06,
      "content": "- 하지만, 조사법인의특수_반품거래금액은거래계약서에기재된"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.34,
        409.47,
        529.75,
        426.29
      ],
      "y0": 409.47,
      "content": "반품기준을위반하였을뿐아니라, 손실을감수하면서까지반품을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        107.34,
        431.77,
        198.37,
        448.58
      ],
      "y0": 431.77,
      "content": "받아준금액임"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        93.07,
        464.13,
        529.75,
        480.95
      ],
      "y0": 464.13,
      "content": "- 반드시이행할의무가없음에도거래처와의관계개선등의목적"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        105.3,
        486.55,
        529.75,
        503.36
      ],
      "y0": 486.55,
      "content": "으로매출채권을임의로포기하여거래상대방에게경제적이익을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        105.3,
        508.96,
        529.03,
        525.78
      ],
      "y0": 508.96,
      "content": "제공한것이므로이는매출과표에서차감하는매출의환입으로"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        105.3,
        531.26,
        213.96,
        548.07
      ],
      "y0": 531.26,
      "content": "볼수없는것임"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        563.62,
        529.75,
        580.44
      ],
      "y0": 563.62,
      "content": "⇒ ‘특수_반품’ 거래금액은VAT 매출과세표준에서차감되는공급가액"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.74,
        586.04,
        529.69,
        602.86
      ],
      "y0": 586.04,
      "content": "(매출환입)에해당하지아니하므로매출과표임의차감액○○○"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        106.74,
        608.46,
        171.87,
        625.27
      ],
      "y0": 608.46,
      "content": "억원적출"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        640.7,
        228.48,
        658.67
      ],
      "y0": 640.7,
      "content": "라. 핵심증거자료확보"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        674.74,
        529.03,
        691.56
      ],
      "y0": 674.74,
      "content": "○(진술확보) 조사법인은‘특수_반품’ 거래가업계의통상적인관행"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.35,
        697.16,
        529.75,
        713.97
      ],
      "y0": 697.16,
      "content": "이라고주장하였으나, 회사의채권관리업무를담당하는채권관리팀"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.35,
        719.45,
        529.75,
        736.27
      ],
      "y0": 719.45,
      "content": "이○○ 부장및기타관련업무종사자들과인터뷰를통해해당"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.35,
        741.87,
        449.76,
        758.68
      ],
      "y0": 741.87,
      "content": "거래는통상적이지않은특수한상황이였음을입증함"
    }
  ],
  "page_16": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        73.6,
        529.03,
        90.42
      ],
      "y0": 73.6,
      "content": "- 일반반품과달리‘특수_반품’의경우거래처뿐아니라조사법인역시"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.23,
        96.02,
        331.5,
        112.83
      ],
      "y0": 96.02,
      "content": "관리책임을소홀히한점을인정함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        165.99,
        128.17,
        428.01,
        141.88
      ],
      "y0": 128.17,
      "content": "< 채권관리팀 이○○부장 문답서 내용 中 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        148.0,
        525.5,
        371.5
      ],
      "y0": 148.0,
      "path": "crops/page_016\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        388.26,
        529.75,
        405.07
      ],
      "y0": 388.26,
      "content": "○(현장증빙확보) 조사팀은조사법인이특수_반품제품에대한폐"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.07,
        410.67,
        529.75,
        427.49
      ],
      "y0": 410.67,
      "content": "기처분여부소명요청에대한회신을회피하자, 물류창고현장방문"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.07,
        432.97,
        529.03,
        449.78
      ],
      "y0": 432.97,
      "content": "하여폐기처리담당여직원으로부터당시촬영해놓은폐기처분"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.07,
        455.38,
        164.19,
        472.2
      ],
      "y0": 455.38,
      "content": "사진확보"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        482.71,
        529.75,
        499.53
      ],
      "y0": 482.71,
      "content": "- 회사는대량폐기처분증빙으로사용할목적으로폐기대상의약품을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.35,
        505.13,
        529.75,
        521.94
      ],
      "y0": 505.13,
      "content": "촬영한사진보관중에있었으며, 담당직원을설득하여관련"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.35,
        527.54,
        191.78,
        544.36
      ],
      "y0": 527.54,
      "content": "사진을확보함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        159.51,
        565.49,
        443.95,
        578.44
      ],
      "y0": 565.49,
      "content": "< 회사가 촬영한 폐기처분 前 증빙사진 확보 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        584.5,
        529.5,
        747.0
      ],
      "y0": 584.5,
      "path": "crops/page_016\\blue_001.png"
    }
  ],
  "page_17": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        78.63,
        529.75,
        95.45
      ],
      "y0": 78.63,
      "content": "○(의약품관리자료참고) 제약회사및도매상은’17년이후부터"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.27,
        100.93,
        529.75,
        117.75
      ],
      "y0": 100.93,
      "content": "제품출하시제조번호, 유효기간, 일련번호등의공급내역정보를"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.27,
        123.35,
        529.03,
        140.16
      ],
      "y0": 123.35,
      "content": "의약품관리종합정보센터(건강보험심사평가원지정)에보고하므로관련"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.27,
        145.76,
        245.99,
        162.58
      ],
      "y0": 145.76,
      "content": "원시자료도적극활용"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        201.61,
        183.71,
        395.26,
        196.66
      ],
      "y0": 183.71,
      "content": "< 의약품 묶음번호 구성 체계 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        202.5,
        528.5,
        410.5
      ],
      "y0": 202.5,
      "path": "crops/page_017\\blue_001.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        183.02,
        438.07,
        415.65,
        451.02
      ],
      "y0": 438.07,
      "content": "< 의약품 일련번호 보고 업무흐름도 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        67.0,
        460.0,
        529.0,
        768.5
      ],
      "y0": 460.0,
      "path": "crops/page_017\\blue_000.png"
    }
  ],
  "page_18": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        83.43,
        279.33,
        101.39
      ],
      "y0": 83.43,
      "content": "마. 적출항목관련법령검토"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        117.59,
        529.75,
        134.42
      ],
      "y0": 117.59,
      "content": "○관련법령및예규·판례를심층검토하여조사팀의접대성경비해당"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.19,
        139.89,
        428.17,
        156.7
      ],
      "y0": 139.89,
      "content": "여부판단등에대한과세논리가타당함을입증함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        167.34,
        529.75,
        184.15
      ],
      "y0": 167.34,
      "content": "⇨ 최신서울청적부심에서유사사례에대한과세처분이정당하다고"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.27,
        189.63,
        191.28,
        206.45
      ],
      "y0": 189.63,
      "content": "판결(2024.1.11.)"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        220.0,
        529.0,
        449.0
      ],
      "y0": 220.0,
      "path": "crops/page_018\\blue_001.png"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        485.0,
        529.0,
        768.0
      ],
      "y0": 485.0,
      "path": "crops/page_018\\blue_000.png"
    }
  ],
  "page_19": [
    {
      "type": "yellow_table",
      "color": "yellow",
      "bbox": [
        68.0,
        78.0,
        529.0,
        134.0
      ],
      "y0": 78.0,
      "content": "적출□\n4\nv 기타 이전가격 (항목코드: 18003)\n제품 고가매입 등을 통한 (결손)해외현지법인 부당지원"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        164.79,
        149.68,
        180.74
      ],
      "y0": 164.79,
      "content": "1. 조사착안"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        203.18,
        240.35,
        221.14
      ],
      "y0": 203.18,
      "content": "가. 착안사항도출과정"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.08,
        237.34,
        529.75,
        254.17
      ],
      "y0": 237.34,
      "content": "○(해외법인인수) 조사법인은’1X.9월베트남○○성에본사를둔"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        93.07,
        259.64,
        529.75,
        276.47
      ],
      "y0": 259.64,
      "content": "의약품원료및완제품생산업체인□□□지분100%를인수(이하"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        93.07,
        282.29,
        176.05,
        297.81
      ],
      "y0": 282.29,
      "content": "‘해외자회사’)"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        307.82,
        529.03,
        324.65
      ],
      "y0": 307.82,
      "content": "- (영업손실) 조사법인이□□□를인수한이후해외자회사는매년"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        92.35,
        330.24,
        263.14,
        347.05
      ],
      "y0": 330.24,
      "content": "영업적자를기록하고있음"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        67.5,
        367.0,
        528.5,
        565.0
      ],
      "y0": 367.0,
      "path": "crops/page_019\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        584.36,
        529.03,
        601.18
      ],
      "y0": 584.36,
      "content": "○(내부거래) 조사법인은\n➊해외자회사에법인장을포함하여4명의"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.31,
        606.78,
        529.75,
        623.61
      ],
      "y0": 606.78,
      "content": "직원을파견하고있으며, ➋’23년부터해외자회사로부터■■■정등"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.31,
        629.07,
        360.76,
        645.89
      ],
      "y0": 629.07,
      "content": "3가지품목의의약품을수입하기시작함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        666.35,
        169.95,
        684.32
      ],
      "y0": 666.35,
      "content": "나. 착안내용"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        700.39,
        529.75,
        717.21
      ],
      "y0": 700.39,
      "content": "○조사법인이해외자회사를인수이래로적자폭이매년증가하였"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.07,
        722.81,
        529.74,
        739.63
      ],
      "y0": 722.81,
      "content": "으나, ’23년해외자회사에서생산한제품을조사법인에서매입(수입)"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.07,
        745.23,
        452.76,
        762.04
      ],
      "y0": 745.23,
      "content": "하기시작하면서적자폭이크게감소한점에착안함"
    }
  ],
  "page_20": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        86.03,
        149.68,
        101.98
      ],
      "y0": 86.03,
      "content": "2. 조사기법"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        124.42,
        232.31,
        142.39
      ],
      "y0": 124.42,
      "content": "가. 적출항목사실관계"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        158.47,
        529.75,
        175.28
      ],
      "y0": 158.47,
      "content": "1) (제품매입) 조사법인은’23년부터해외자회사에서생산한의약품을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.87,
        180.88,
        521.12,
        197.71
      ],
      "y0": 180.88,
      "content": "수입하기시작하였으며, 수입의약품은■■■정등3가지품목임"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        84.43,
        213.25,
        529.73,
        230.08
      ],
      "y0": 213.25,
      "content": "- 수입품목인■■■정에대한의약품정보를약학정보원(www.health.kr)"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        95.35,
        235.66,
        529.03,
        252.49
      ],
      "y0": 235.66,
      "content": "사이트에검색한바, ■■■정은조사법인이’9X. 8월허가(신약) 받아"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        95.35,
        257.96,
        406.1,
        274.77
      ],
      "y0": 257.96,
      "content": "이미국내공장에서생산중인품목인것으로확인"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        158.19,
        295.91,
        431.24,
        308.86
      ],
      "y0": 295.91,
      "content": "< △△정, 약학정보원 의약품 상세정보 자료 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        311.0,
        507.0,
        465.5
      ],
      "y0": 311.0,
      "path": "crops/page_020\\blue_000.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        85.63,
        477.08,
        529.75,
        493.89
      ],
      "y0": 477.08,
      "content": "- 이에수입한품목들에대한수입단가와자체(국내) 생산단가를비교한바"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        97.03,
        499.37,
        478.66,
        516.19
      ],
      "y0": 499.37,
      "content": "자체생산단가는수입단가의절반정도수준인것으로확인"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        558.5,
        526.5,
        687.0
      ],
      "y0": 558.5,
      "path": "crops/page_020\\blue_001.png"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.11,
        725.93,
        529.75,
        742.74
      ],
      "y0": 725.93,
      "content": "생산관리업무등을수행하게하고, 파견직원에대한인건비및"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.11,
        748.34,
        488.74,
        765.16
      ],
      "y0": 748.34,
      "content": "각종체재비등을조사법인에서지급하고있는것으로확인"
    }
  ],
  "page_21": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        65.12,
        83.43,
        180.62,
        101.39
      ],
      "y0": 83.43,
      "content": "나. 적출내역"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        117.59,
        529.75,
        134.41
      ],
      "y0": 117.59,
      "content": "1) (고가매입) 해외자회사로부터의의약품매입거래에대하여거래순"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.11,
        141.33,
        529.03,
        158.14
      ],
      "y0": 141.33,
      "content": "이익률법(TNMM)을기초로정상가격산출한바조사법인은정상가격"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.11,
        165.06,
        313.03,
        181.88
      ],
      "y0": 165.06,
      "content": "보다고가로매입한사실을확인"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        193.83,
        527.47,
        210.66
      ],
      "y0": 193.83,
      "content": "- 정상가격보다고가매입한이전가격과세표준누락액○○억원적출"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        227.63,
        529.75,
        244.45
      ],
      "y0": 227.63,
      "content": "2) (용역수수료누락) 조사법인은해외자회사에직원을파견하여생산"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.23,
        251.37,
        529.75,
        268.18
      ],
      "y0": 251.37,
      "content": "관리업무등을수행하게하면서파견직원에대한인건비및"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.23,
        275.22,
        529.75,
        292.03
      ],
      "y0": 275.22,
      "content": "체재비등을부담하고있으나, 해외자회사로부터용역수수료등을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.23,
        298.95,
        224.16,
        315.77
      ],
      "y0": 298.95,
      "content": "수취하고있지않음"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        327.72,
        529.75,
        344.54
      ],
      "y0": 327.72,
      "content": "- 조사법인이해외파견직원에대하여지급한인건비등에5% 이윤을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        98.11,
        351.46,
        433.09,
        368.29
      ],
      "y0": 351.46,
      "content": "가산(Mark-up)한용역수수료누락액○○억원적출"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        72.08,
        390.17,
        234.59,
        408.14
      ],
      "y0": 390.17,
      "content": "다. 핵심증거자료확보"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        79.16,
        427.21,
        529.75,
        444.03
      ],
      "y0": 427.21,
      "content": "○(내부보고서) 해외자회사가계속적인적자가발생하자이익을"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.87,
        449.63,
        529.03,
        466.44
      ],
      "y0": 449.63,
      "content": "분여할목적으로국내생산품목을해외자회사가생산하게하고"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.87,
        471.92,
        529.03,
        488.74
      ],
      "y0": 471.92,
      "content": "고가로\n매입하는\n전략을\n수립한‘해외자회사\n흑자전환\n운영"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        100.87,
        494.34,
        304.88,
        511.16
      ],
      "y0": 494.34,
      "content": "보고서’를예치서류에서확보함"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        171.87,
        532.29,
        437.0,
        545.24
      ],
      "y0": 532.29,
      "content": "< 해외자회사 흑자전환 운영 보고서 발췌 >"
    },
    {
      "type": "blue_table",
      "color": "blue",
      "bbox": [
        66.0,
        556.5,
        526.5,
        763.5
      ],
      "y0": 556.5,
      "path": "crops/page_021\\blue_000.png"
    }
  ],
  "page_22": [
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        86.11,
        78.63,
        529.75,
        95.45
      ],
      "y0": 78.63,
      "content": "- ‘흑자전환운영보고서’에따르면, 조사법인은해외자회사의경영"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.19,
        102.37,
        529.75,
        119.18
      ],
      "y0": 102.37,
      "content": "정상화를위하여의약품수입단가를상향하고, 이에따라매입"
    },
    {
      "type": "purple_text",
      "color": "purple",
      "bbox": [
        99.19,
        126.1,
        488.97,
        142.92
      ],
      "y0": 126.1,
      "content": "처인조사법인은총이익률이감소한다는내용이담겨있음"
    }
  ]
}